Lexology July 17, 2024
McCarter & English LLP

Through its recent decision in Loper Bright Enterprises v. Raimondo, No. 22-451 (S. Ct. June 28, 2024), the US Supreme Court overturned the landmark decision in Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (1984).

Impact on Healthcare Regulations

Federal agencies that oversee federal healthcare programs and have regulatory authority, such as the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services, issue a significant number of regulations on an annual basis that impact healthcare. With the reversal of Chevron, it is likely that there will be an increase in challenges to regulations brought by entities, such as providers, that are impacted by these regulations. In addition, the reversal of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
Overturning Chevron Doctrine Could Impact Medicare’s Drug Selections For Price Negotiations
OpenAI, Australia and EU Each Push Own AI Regulations
What The Election Means For Federal Health Care Legislation
A ‘lamer-than-usual’ lame duck?
The European Union AI Act: Time to start preparing

Share This Article